Ionis shares positive clinical update from ongoing trial of ION582 for Angelman syndrome ...Middle East

News by : (PR Newswire) -
Part 1 of HALOS trial evaluating ION582 has completed enrollment with results expected in mid-2024 ION582 has been generally well tolerated at all dose levels, and participants are continuing to Part 2, the long-term extension portion of the study Encouraging EEG and clinical observations...

Hence then, the article about ionis shares positive clinical update from ongoing trial of ion582 for angelman syndrome was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Ionis shares positive clinical update from ongoing trial of ION582 for Angelman syndrome )

Last updated :

Also on site :

Most Viewed News
جديد الاخبار